Didier Raoult

5 ta ish

Institute of Research for Development

1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

   Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa +45

   Maqola20175 iqtibos

   ABIABI:AkademIndex/2026.other.339917

2. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

   Marie Vétizou, Jonathan M. Pitt, Romain Daillère +35

   Maqola20154 iqtibos

   ABIABI:AkademIndex/2026.other.339891

3. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

   Romain Daillère, Marie Vétizou, Nadine Waldschmitt +33

   Maqola20163 iqtibos

   ABIABI:AkademIndex/2026.other.480493

4. RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

   Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola +15

   Maqola20202 iqtibos

   ABIABI:AkademIndex/2026.other.318507

5. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

   Philippe Colson, Jean‐Marc Rolain, Jean‐Christophe Lagier +2

   Boshqa20202 iqtibos

   ABIABI:AkademIndex/2026.other.507194